(Hypertension. 2001;37:1191.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson.
Correspondence to Joey P. Granger, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail jgranger{at}physiology.umsmed.edu
| Abstract |
|---|
|
|
|---|
Key Words: preeclampsia hypertension, pregnancy glomerular filtration rate renal blood flow plasma endothelium nitric oxide
| Introduction |
|---|
|
|
|---|
The initiating event in preeclampsia is suggested to involve reduced placental perfusion, which leads to maternal endothelial cell dysfunction.1 3 4 The factors involved in mediating the hypertension during preeclampsia are unknown and may involve a delicate balance of vasoconstrictors and vasodilators of which nitric oxide (NO) may play an important role.1 4 6 Evidence indicates that NO plays an important role in mediating physiological changes during normal pregnancy.6 7 Increases in regional blood flow, RPF, and GFR during pregnancy are attenuated by systemic NO synthesis inhibition.8 9 Urinary excretion of cGMP, a second messenger of NO, and nitrite/nitrate, metabolites of NO, are increased during normal pregnancy.10 Therefore, as NO may play an important role in normal pregnancy, NO deficiency may play an important role in preeclampsia.2 6 It is unclear, however, whether NO production is reduced during preeclampsia because it is difficult to accurately assess the NO system in humans. For example, measurement of whole-body NO in clinical settings has yielded variable results caused by difficulties in controlling for nitrate intake.2 In addition, whole-body NO production may not be an accurate measure of the NO system activity in specific tissues such as the kidneys.11 12
During normal pregnancy in the rat, increases in whole-body NO production and changes in renal hemodynamics are associated with increases in renal protein expression of both neuronal (nNOS) and inducible (iNOS) nitric oxide synthase isoforms.13 Although the NO system has been well characterized during normal pregnancy in the rat, information regarding the activity of the NO system in animal models of pregnancy-induced hypertension (PIH) is lacking. Thus, the overall goal of this study was to assess whole-body NO production under fixed nitrate intake conditions in a rat model of PIH induced by chronic reductions in uterine perfusion pressure. In addition, because the kidneys play a major role in the long-term regulation of arterial pressure and because abnormalities in the renal pressure-natriuresis relation have been observed in all forms of hypertension examined to date, another goal of this study was to assess the changes in renal hemodynamics and renal protein expression of the NOS isoforms that occur in response to reduced uterine perfusion pressure (RUPP) in pregnant rats.
| Methods |
|---|
|
|
|---|
RUPP Model in Rat
Chronic reductions in uteroplacental perfusion in
rats, previously reported by Eder and
McDonald,14 reduced uterine
perfusion pressure by 35% to 45% during mid to late gestation by
placing a silver clip or a silk ligature around the aorta below the
renal arteries. We used a modification of this model to examine the
role of NO in mediating hypertension during chronic reductions in
uterine perfusion pressure. All rats undergoing surgical procedures
were anesthetized with 2%
isoflurane.8 Pregnant rats
entering the RUPP group underwent the following clipping procedure at
day 14 of gestation. After a midline incision, the lower abdominal
aorta was isolated and a silver clip (0.203-mm ID) was placed around
the aorta above the iliac bifurcation. In preliminary studies, we have
found this procedure to reduce uterine perfusion pressure in the gravid
rat by
40%. Because compensation of blood flow to the placenta
occurs in pregnant rats through an adaptive increase in ovarian
blood flow, we also clipped branches of both the right and left
ovarian arteries that supply the uterus by using a silver clip
(0.100-mm ID). When the clipping procedure resulted in total
reabsorption of the fetuses, rats were excluded from data
analyses. A total of 15 normal pregnant and 18 RUPP rats were
used for data collection in the metabolic studies, from
which 8 normal pregnant and 10 RUPP rats were analyzed for
renal NOS protein expression. All rats undergoing metabolic
studies were surgically instrumented with catheters (PE 50 tubing) in
the carotid artery for blood pressure monitoring. A total of 12 normal
pregnant and 9 RUPP rats were used for renal and systemic
hemodynamic analyses.
The effect of chronic reductions in uterine perfusion pressure on systemic arterial pressure was also examined in virgin rats. A total of 6 virgin rats underwent the same surgical procedures as in the RUPP rats described above. Blood pressure in these virgin clipped rats was compared with control virgin rats (n=7).
Measurement of Renal
Hemodynamics and Arterial Pressure in
Conscious Rats
Renal hemodynamics and
arterial pressures were determined in conscious control
pregnant (n=12) and RUPP (n=9) animals at day 19 of gestation. Similar
surgical procedures for monitoring of blood pressure were performed in
virgin control and virgin clipped rats. Measurements of renal
hemodynamics and arterial pressures in
conscious rats were performed as previously described by the
authors.13
Measure of Urinary Nitrite/Nitrate
Excretion
Urinary nitrite/nitrate excretion rates were
determined in both control pregnant (n=15) and RUPP (n=18) animals fed
a low nitrite/nitrate diet (AIN76, ICN Pharmaceuticals Inc) for 5 days
before collection. Measure of urinary nitrite/nitrate was performed as
previously described by the
authors.13
Determination of Urinary Protein Levels
Urinary excretion of protein was measured in both
control pregnant (n=15) and RUPP (n=18) animals with 24-hour urine
collection and storage of a final sample at -20°C. Protein
concentration was determined with a Sigma Protein Determination kit
(P5656, Sigma Chemical
Co).15
Measure of Plasma Estradiol 17-ß and
Progesterone Levels
Plasma estradiol and progesterone concentrations were
determined by chemiluminescence immunoassay with the Chiron ACS-180
autoanalyzer (Chiron Diagnostics Corp). The assay
sensitivity for estradiol and progesterone was 10 pg/mL and <0.1
ng/mL, respectively. The within-assay precision (%CV) was
5.0% and
the between-assay precision was
9.2%.
Isolation of Total Cellular Proteins and
Western Blot Analyses
Kidneys were removed from control pregnant (n=8) and
RUPP (n=10) rats at day 19 of pregnancy, quick-frozen in liquid
nitrogen, then stored at -80°C. Isolation of total cellular
proteins and Western blot analyses of the renal NOS isoforms
were performed as previously described by the
authors.13
Statistical Analysis
All data are expressed as mean±SEM. Comparisons of
control pregnant rats with RUPP rats and comparisons between virgin
control and virgin clipped rats were analyzed by factorial
ANOVA followed by Scheffés test. A value of
P<0.05 was considered
statistically significant.
| Results |
|---|
|
|
|---|
126±7 mm Hg (P<0.05)
in the RUPP rats at day 19 of pregnancy. This was a significant
increase as compared with an average MAP of 103±4 mm Hg observed
in control pregnant rats. In contrast, reductions in uterine perfusion
pressure in virgin rats resulted in no significant effects on
arterial pressure relative to control virgin rats
(Figure 2). MAP averaged
113±3 mm Hg in the clipped
virgin rats and 112±10 mm Hg in the virgin control
rats.
|
|
Although not significant, an increase in urinary protein excretion was also observed in the RUPP model when compared with normal pregnancy (108±15 and 15±2 mg/24 hours, respectively) (Figure 3). Intrauterine growth restriction, another hallmark of human preeclampsia, was also evident as pup weights were slightly decreased in RUPP animals relative to control pregnant animals (2.68±0.22 and 3.18±0.19 g, respectively). In addition, at day 19 of pregnancy, the RUPP model was also associated with decreased litter size (7.3±0.48 and 10.438±0.63 pups, respectively, P<0.05) as well as decreased body weight (248.4±7.14 and 307.9±0.36 g, respectively, P<0.05).
|
Effects of Chronic Reductions in Uterine
Perfusion Pressure on Renal Hemodynamics
The renal hemodynamic changes observed
in the RUPP animals relative to normal pregnant animals are illustrated
in
Figure 4. Both GFR (1.29±0.42 and 2.21±0.14 mL/min,
respectively, P<0.05) and RPF
(4.57±1.17 and 5.91±0.67 mL/min, respectively) decreased in the RUPP
model relative to normal pregnancy at day 19, with a significant
reduction occurring in GFR.
|
Effects of Chronic Reductions in Uterine
Perfusion Pressure on Urinary Nitrite/Nitrate Levels
Urinary nitrite/nitrate excretion was measured to
estimate whole-body production of NO. At day 19 of pregnancy,
excretion of nitrite/nitrate in the RUPP model (49.8±6.4 µmol/24
hours) did not differ significantly compared with normal pregnancy
(46.4±5.3 µmol/24 hours)
(Figure 5).
|
Effects of Chronic Reductions in Uterine
Perfusion Pressure on Plasma Levels of Estradiol 17-ß and
Progesterone
No significant changes were observed in plasma hormone
levels in the RUPP model. A slight but nonsignificant decrease in
plasma estradiol 17-ß was observed in the RUPP animals relative to
normal pregnant animals (49.9±6.1 versus 62.4±8.9 pg/mL,
respectively), whereas a slight but nonsignificant increase in plasma
progesterone was observed (107.7±12.9 versus 83.4±8.5 ng/mL,
respectively).
Effects of Chronic Reductions in Uterine
Perfusion Pressure on Renal Protein Expression of NOS
Isoforms
Comparable levels of renal endothelial
NOS (eNOS) protein expression were found at day 19 of pregnancy in both
the RUPP and control pregnant animals
(Figure 6). However, renal protein expression of both iNOS
and nNOS were decreased at day 19 of pregnancy in the RUPP animals
relative to control pregnant animals
(Figure 6). Renal iNOS expression decreased by 11% in the
RUPP model as compared with normal pregnancy, whereas renal nNOS
expression decreased by 31%
(P<0.05). Therefore, a
significant decrease in renal nNOS expression was observed in the RUPP
rats.
|
| Discussion |
|---|
|
|
|---|
40 mm Hg in rats
at mid-gestation. Because compensation of blood flow to the placenta
occurs in pregnant rats through an adaptive increase in ovarian
blood flow, we also placed silver clips on branches of both the right
and left ovarian arteries that supply the uterus. In this
study, we report that the RUPP model in the conscious rat is
characterized by increases in arterial pressure and urinary
protein excretion, decreases in GFR and RPF, and intrauterine growth
restriction. Thus, the RUPP model in the rat has many features similar
to those of humans with PIH. A major goal of this study was to determine whether whole-body and renal NO production is reduced in the RUPP model. Although a deficiency in NO production has been suggested to play a role in PIH, clinical assessment of whole-body NO production in preeclampsia has given rise to varied results caused by differences in dietary intake, exercise, and duration of urine collection.11 In our study, 24-hour urine collections representing steady-state levels of NO production on animals fed a low nitrite/nitrate diet were measured to provide a more accurate measure of whole-body NO synthesis. No change in whole-body NO production as determined by urinary nitrite/nitrate excretion was observed in the RUPP animals. However, whole-body NO production may not be indicative of the NO synthesis in specific tissues such as the kidney.11 12
Because the kidneys play a major role in the long-term regulation of arterial pressure and abnormalities in the renal pressure-natriuresis relation have been observed in all forms of hypertension examined to date, another goal of this study was to assess renal NO production in the RUPP model. As a means of investigating the NO system in the kidney, we examined the renal protein expression of the NOS isoforms in the RUPP model. We observed no difference in renal eNOS protein expression at day 19 of pregnancy in the RUPP rats as compared with control pregnant rats. However, renal iNOS protein expression in RUPP animals was decreased by 11% as compared with normal pregnancy and renal nNOS by 31%. Thus, renal nNOS protein expression in the RUPP rats was significantly decreased, and this decrease was associated with a significant decrease in GFR of 40% and a decrease in RPF of 23%.
Therefore, the significant reductions in renal hemodynamics observed in the RUPP model in the rat were associated with significant reductions in renal expression of the nNOS isoform. Recent studies suggest that NO produced by either eNOS or iNOS does not play a significant role in mediating the renal hemodynamic changes observed during normal pregnancy.13 18 19 However, NO generated from nNOS has been implicated in mediating the increase in hemodynamics observed during normal pregnancy.13 18 20 Whether the decrease in renal nNOS protein expression is involved in mediating the decrease in renal hemodynamics in the RUPP model is unclear. We have recently reported, however, that inhibition of nNOS with 7-nitroindazole significantly reduces RPF and GFR in pregnant rats but not virgin rats.20 Therefore, NO generated by nNOS in the kidney may be involved in the long-term control of renal hemodynamic changes that occur during normal gestation, and variations in renal nNOS expression may contribute to changes in renal hemodynamics during preeclampsia.
Summary
We found that a chronic reduction in uterine perfusion
pressure in the pregnant rat was associated with significant increases
in arterial pressure and decreases in GFR. In addition,
decreases in RPF, proteinuria, and intrauterine growth restriction were
also observed in the RUPP animals. Thus, the RUPP model in the rat
closely resembles many of the features observed in women with PIH.
Although hypertension in the RUPP model was not associated with
significant reductions in whole-body NO synthesis, as assessed by
urinary excretion of nitrite/nitrate, significant reductions in renal
protein expression of the nNOS isoform were found. These changes in
renal nNOS expression may contribute to changes in renal
hemodynamics and possibly the hypertension observed
during chronic reductions in uterine perfusion pressure in the
rat.
| Acknowledgments |
|---|
Received July 20, 2000; first decision September 11, 2000; accepted September 29, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF] |
||||
![]() |
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sholook, J. S. Gilbert, M. H. Sedeek, M. Huang, R. L. Hester, and J. P. Granger Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2080 - H2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Granger Response to Modeling Preeclampsia: The True Model for the Uniquely Human Disease Preeclampsia Is the Human Female Not the Pregnant Rat Hypertension, April 1, 2007; 49(4): e22 - e22. [Full Text] [PDF] |
||||
![]() |
G. Pridjian, C. Pridjian, S. Danchuk, M. Ianosi-Irimie, H. V. Vu, and J. B. Puschett Beneficial Effects of Metolazone in a Rat Model of Preeclampsia J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1027 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Roberts, B. B. D. LaMarca, L. Fournier, J. Bain, K. Cockrell, and J. P. Granger Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion Hypertension, March 1, 2006; 47(3): 615 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. D. LaMarca, W. A. Bennett, B. T. Alexander, K. Cockrell, and J. P. Granger Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Tumor Necrosis Factor-{alpha} Hypertension, October 1, 2005; 46(4): 1022 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shah Role of the renin-angiotensin system in the pathogenesis of preeclampsia Am J Physiol Renal Physiol, April 1, 2005; 288(4): F614 - F625. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, A. E. Hendon, G. Ferril, and T. M. Dwyer Renal Denervation Abolishes Hypertension in Low-Birth-Weight Offspring From Pregnant Rats With Reduced Uterine Perfusion Hypertension, April 1, 2005; 45(4): 754 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cherla and E. A. Jaimes Role of L-Arginine in the Pathogenesis and Treatment of Renal Disease J. Nutr., October 1, 2004; 134(10): 2801S - 2806S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Orshal and R. A. Khalil Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, M. T. Llinas, W. C. Kruckeberg, and J. P. Granger L-Arginine Attenuates Hypertension in Pregnant Rats With Reduced Uterine Perfusion Pressure Hypertension, April 1, 2004; 43(4): 832 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Llinas, B. T. Alexander, M. F. Capparelli, M. A. Carroll, and J. P. Granger Cytochrome P-450 Inhibition Attenuates Hypertension Induced by Reductions in Uterine Perfusion Pressure in Pregnant Rats Hypertension, March 1, 2004; 43(3): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Orshal and R. A. Khalil Reduced Endothelial NO-cGMP-Mediated Vascular Relaxation and Hypertension in IL-6-Infused Pregnant Rats Hypertension, February 1, 2004; 43(2): 434 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Payne, B. T. Alexander, and R. A. Khalil Decreased Endothelium-Dependent NO-cGMP Vascular Relaxation and Hypertension in Growth-Restricted Rats on a High-Salt Diet Hypertension, February 1, 2004; 43(2): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Payne, B. T. Alexander, and R. A. Khalil Reduced Endothelial Vascular Relaxation in Growth-Restricted Offspring of Pregnant Rats With Reduced Uterine Perfusion Hypertension, October 1, 2003; 42(4): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Isler, W. A. Bennett, A. N. Rinewalt, K. L. Cockrell, J. N. Martin Jr., J. C. Morrison, and J. P. Granger Evaluation of a Rat Model of Preeclampsia for HELLP Syndrome Characteristics Reproductive Sciences, April 1, 2003; 10(3): 151 - 153. [Abstract] [PDF] |
||||
![]() |
B. T. Alexander Placental Insufficiency Leads to Development of Hypertension in Growth-Restricted Offspring Hypertension, March 1, 2003; 41(3): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Murphy, J. N. Herrington, J. P. Granger, and R. A. Khalil Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H393 - H403. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Giardina, G. M. Green, K. L. Cockrell, J. P. Granger, and R. A. Khalil TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R130 - R143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davis, J. B. Giardina, G. M. Green, B. T. Alexander, J. P. Granger, and R. A. Khalil Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha -induced hypertension in pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R390 - R399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Davisson, D. S. Hoffmann, G. M. Butz, G. Aldape, G. Schlager, D. C. Merrill, S. Sethi, R. M. Weiss, and J. N. Bates Discovery of a Spontaneous Genetic Mouse Model of Preeclampsia Hypertension, February 1, 2002; 39(2): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, K. Cockrell, F. D. Cline, and J. P. Granger Inducible Nitric Oxide Synthase Inhibition Attenuates Renal Hemodynamics During Pregnancy Hypertension, February 1, 2002; 39(2): 586 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, W. A. Bennett, R. A. Khalil, and J. P. Granger Preeclampsia: Linking Placental Ischemia with Cardiovascular-Renal Dysfunction Physiology, December 1, 2001; 16(6): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Granger, B. T. Alexander, M. T. Llinas, W. A. Bennett, and R. A. Khalil Pathophysiology of Hypertension During Preeclampsia Linking Placental Ischemia With Endothelial Dysfunction Hypertension, September 1, 2001; 38(3): 718 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Barron, J. B. Giardina, J. P. Granger, and R. A. Khalil High-Salt Diet Enhances Vascular Reactivity in Pregnant Rats With Normal and Reduced Uterine Perfusion Pressure Hypertension, September 1, 2001; 38(3): 730 - 735. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||